Factory 99% Neomycin Sulfate Powder CAS 1405-10-3 Antibacterial Neomycin Sulfate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A206
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Neomycin Sulfate
• CAS: 1405-10-3
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Antibacterial
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Neomycin Sulfate
Appearance	White Powder
CAS NO.	1405-10-3
Molecular Formula	C23H52N6O25S3
Storage	Keep in a cool, dry, dark location

Neomycin Sulfate is an aminoglycoside antibiotic derived from microorganisms. It has the molecular formula C23H52N6O25S3 and a molecular weight of approximately 908.88. It functions by irreversibly binding to the 30S ribosomal subunit of bacteria, thereby inhibiting bacterial protein synthesis and exerting antibacterial activity.

1. Antibacterial Agent: Neomycin Sulfate is widely used as an antibacterial agent in various medical and veterinary applications.
2. Pharmaceutical Formulations: It is often included in topical preparations such as ointments, creams, and eye drops for the treatment of bacterial infections.
3. Research and Development: Due to its unique mechanism of action, Neomycin Sulfate is also used in research settings to study bacterial ribosome function and antibiotic resistance.

1. Antibacterial Activity: Neomycin Sulfate is effective against most Gram-negative bacteria except Pseudomonas aeruginosa and anaerobes. It also has activity against some Gram-positive bacteria, particularly Staphylococcus species.
2. Phospholipase C (PLC) Inhibitor: Neomycin Sulfate acts as a known inhibitor of phospholipase C, which may contribute to its anti-inflammatory properties.
3. Inhibition of Angiogenesis: It has been shown to inhibit the nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis, suggesting potential applications in anti-cancer therapy.